Skip to main content
Equibles

FMR LLC

Position in NERV — Minerva Neurosciences, Inc.

CIK 315066 BOSTON, MA
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,315
+$1,315 QoQ
Shares Held
237
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 58 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. NERV ranks #324 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in NERV

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,315 237
2025-09-30 $0 0
2025-06-30 $0 0
2025-03-31 $42 25
2024-12-31 $0 0
2024-09-30 $0 0
2023-12-31 $3,024,237 491,746
2023-09-30 $3,393,047 491,746
2023-06-30 $4,494,558 491,746
2022-09-30 $260,950 28,272
2022-06-30 $165,920 50,127
2022-03-31 $332,852 401,027
2021-12-31 $181,252 226,283
2021-09-30 $686,393 394,479
2021-06-30 $915,191 394,479
2021-03-31 $1,151,878 394,479
2020-12-31 $925,420 395,479
2020-09-30 $1,453,148 456,965
2020-06-30 $5,368,120 1,487,014
2020-03-31 $11,720,422 1,946,914